Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study

Eur J Surg Oncol. 2016 Jul;42(7):1064-70. doi: 10.1016/j.ejso.2016.01.023. Epub 2016 Feb 13.

Abstract

Background: Extra-pleural and extra-meningeal solitary fibrous tumour (SFT) is a rare sarcoma histotype curable with surgery in the majority of patients. The behaviour of these tumours ranges from indolent/very low grade to malignant/high grade but it is still not possible to accurately predict prognosis after surgery. We have investigated a multi-centre series to stratify the risk of recurrence to patients with SFTs.

Methods: We retrospectively analysed the data from 243 patients who underwent surgery (2002-2011) at four sarcoma referral centres.

Results: Upon univariate analysis, hypercellularity, atypia, necrosis, high mitotic rate (ie >4 mitoses/10 HPF) were associated with both disease-free and overall survival. Surgical margins were a significant prognostic factor for disease-free (P = 0.007) but not for overall survival. Unexpectedly, larger tumour size was associated with a better prognosis (P = 0.038) and fewer recurrences (P = 0.024). Upon multivariable analysis, high mitotic rate (hazard ratio, HR = 2.85, P = 0.002), cellular atypia (HR = 1.62, P = 0.015) and hypercellularity (HR = 1.82, P = 0.031) were significantly associated with recurrences. A SFT recurrence score has been provided to stratify risk of recurrence.

Conclusion: This study provides a prognostic model to stratify risk of recurrence in patients with resectable SFTs. This allows clinician to decide on an optimal follow-up strategy and to select patients that may benefit from adjuvant treatments.

Keywords: Haemangiopericytoma; Prognosis; Sarcoma; Solitary fibrous tumour.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Margins of Excision
  • Middle Aged
  • Mitotic Index
  • Necrosis
  • Neoplasm Recurrence, Local / diagnosis
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Solitary Fibrous Tumors / pathology*
  • Solitary Fibrous Tumors / surgery*